2008
Psoriasis: an opportunity to identify cardiovascular risk
Federman DG, Shelling M, Prodanovich S, Gunderson CG, Kirsner RS. Psoriasis: an opportunity to identify cardiovascular risk. British Journal Of Dermatology 2008, 160: 1-7. PMID: 19016698, DOI: 10.1111/j.1365-2133.2008.08874.x.Peer-Reviewed Original ResearchConceptsCardiovascular risk factorsCardiovascular riskRisk factorsTreatable cardiovascular risk factorsPatients' cardiovascular riskMyocardial infarctionSevere diseaseHealth professionalsPsoriasisPatientsRiskLow qualityAssociationArthritisInfarctionAtherosclerosisInflammationMortalityFactorsPrevalenceDermatologistsDiseaseComplaints
2001
Fatal Rhabdomyolysis Caused by Lipid-Lowering Therapy
FEDERMAN D, HUSSAIN F, WALTERS J. Fatal Rhabdomyolysis Caused by Lipid-Lowering Therapy. Southern Medical Journal 2001, 94: 1023-1026. PMID: 11702815, DOI: 10.1097/00007611-200110000-00016.Peer-Reviewed Original ResearchConceptsStatin therapyFatal rhabdomyolysisHigh-dose statin therapyDose statin therapySevere lipid abnormalitiesLipid-Lowering TherapyCoronary artery diseaseCombination of simvastatinTreatment of hypercholesterolemiaRenal insufficiencyLipid abnormalitiesArtery diseaseCombination therapyRisk factorsTherapyRhabdomyolysisAdditional agentsPatientsFibratesHypercholesterolemiaInsufficiencyMortalitySimvastatinAbnormalitiesCliniciansFatal Rhabdomyolysis Caused by Lipid-Lowering Therapy
FEDERMAN D, HUSSAIN F, WALTERS J. Fatal Rhabdomyolysis Caused by Lipid-Lowering Therapy. Southern Medical Journal 2001, 94: 1023-1026. DOI: 10.1097/00007611-200194100-00017.Peer-Reviewed Original ResearchStatin therapyFatal rhabdomyolysisHigh-dose statin therapyDose statin therapySevere lipid abnormalitiesLipid-Lowering TherapyCoronary artery diseaseCombination of simvastatinTreatment of hypercholesterolemiaRenal insufficiencyLipid abnormalitiesArtery diseaseCombination therapyRisk factorsTherapyRhabdomyolysisAdditional agentsPatientsFibratesHypercholesterolemiaInsufficiencyMortalitySimvastatinAbnormalitiesClinicians